CD133 and ABCB5 as stem cell markers on sentinel lymph node from melanoma patients

European Journal of Surgical Oncology

Volumn 36, Issue 12, 2010, Pages 1211-1214

  Gazzaniga, P ^a   Cigna, E ^a   Panasiti, V ^a   Devirgiliis, V ^a   Bottoni, U ^b   Vincenzi, B ^c   Nicolazzo, C ^a   Petracca, A ^a   Gradilone, A ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

ABCB5; CD133; Melanoma; Prominin 1; SLN

Indexed keywords

ABCB5 PROTEIN; CD133 ANTIGEN; PROTEIN; UNCLASSIFIED DRUG; ABCB5 PROTEIN, HUMAN; GLYCOPROTEIN; GLYCOPROTEIN P; LEUKOCYTE ANTIGEN; PEPTIDE; TUMOR MARKER;

ARTICLE; CANCER STAGING; CANCER STEM CELL; CARCINOGENICITY; CELL FRACTIONATION; CELL POPULATION; CUTANEOUS MELANOMA; DOWN REGULATION; EMBRYONIC STEM CELL; HUMAN; IMMUNOHISTOCHEMISTRY; MELANOMA; MELANOMA CELL; METASTATIC MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; STEM CELL; ADULT; AGAR GEL ELECTROPHORESIS; AGED; CHEMISTRY; FEMALE; LYMPH NODE; MALE; MIDDLE AGED; PATHOLOGY; SKIN TUMOR;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ELECTROPHORESIS, AGAR GEL; FEMALE; GLYCOPROTEINS; HUMANS; LYMPH NODES; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; NEOPLASTIC STEM CELLS; P-GLYCOPROTEIN; PEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 78649449424     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2010.05.001     Document Type: Article

References (13)

1. Grichnik JM. Melanoma, nevogenesis, and stem cell biology. J Invest Dermatol 2008;128:2365-80.
2. Fang D, Nguyen TK, Leishear K, et al. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 2005;65:9328-37. (Pubitemid 41508000)
3. Rappa G, Fodstad O, Lorico A. The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. Stem Cells 2008;26:3008-17.
4. Frank NY, Pendse SS, Lapchak PH, et al. Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter. J Biol Chem 2003;278:47156-65. (Pubitemid 37452302)
5. Frank NY, Margaryan A, Huang Y, et al. ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res 2005;65:4320-33. (Pubitemid 40775671)
6. Zabierowski SE, Herlyn M. Melanoma stem cells: the dark seed of melanoma. J Clin Oncol 2008;26:2890-4.
7. Zabierowski SE, Herlyn M. Learning the ABCs of melanoma-initiating cells. Cancer Cell 2008;13:185-7. (Pubitemid 351318377)
8. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001;19:3635-48. (Pubitemid 32786276)
9. Bach CM, Gershenwald JE, Soong S, et al. Final Version of 2009 AJCC Melanoma Staging and Classification. J Clin Oncol 2009;27: 6199-206.
10. Gradilone A, Gazzaniga P, Ribuffo D, et al. Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients. J Clin Oncol 2003;21:306-12. (Pubitemid 46606160)
11. Smith B, Selby P, Southgate J, et al. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991;338:1227-9.
12. Gradilone A, Cigna E, Aglianò AM,et al.Tyrosinase expression as a molecular marker for investigating the presence of circulating tumor cells in melanoma patients. Curr Cancer Drug Targets 2010;10:529-38.
13. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid-guanidiumthiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9. (Pubitemid 17064313)